Immune response in chronic obstructive pulmonary disease (Q38144104)

29 August 2017

Immune response in chronic obstructive pulmonary disease (English)

1 reference

chronic obstructive pulmonary disease

29 August 2017

1 reference

Rosa Faner

1

0 references

author name string

Tamara Cruz

series ordinal

2

1 reference

PubMed ID

24070046

29 August 2017

Alvar Agusti

series ordinal

3

1 reference

29 August 2017

1 September 2013

1 reference

Expert Review of Clinical Immunology

29 August 2017

1 reference

29 August 2017

9

1 reference

29 August 2017

9

1 reference

29 August 2017

821-833

1 reference

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary

29 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Global burden of COPD: risk factors, prevalence, and future trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

The global burden of disease, 1990–2020

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

The nature of small-airway obstruction in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Immunologic aspects of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Familial aggregation of FEF(25-75) and FEF(25-75)/FVC in families with severe, early onset COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Hypothesis: does COPD have an autoimmune component?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Characterisation of COPD heterogeneity in the ECLIPSE cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Chronic obstructive pulmonary disease in non-smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Biological dust exposure in the workplace is a risk factor for chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

The natural history of chronic airflow obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Investigating the natural history of lung function: facts, pitfalls, and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Variants in FAM13A are associated with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

COPD: a pediatric disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Abnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

An investigation of the resolution of inflammation (catabasis) in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Defining criteria for autoimmune diseases (Witebsky's postulates revisited)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Bronchus associated lymphoid tissue (BALT) in human lung: its distribution in smokers and non-smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

The HLA system. First of two parts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

CD8+ T cells in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Marked alveolar apoptosis/proliferation imbalance in end-stage emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Cytotoxic potential of lung CD8(+) T cells increases with chronic obstructive pulmonary disease severity and with in vitro stimulation by IL-18 or IL-15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Lung CD8+ T cells in COPD have increased expression of bacterial TLRs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

CC chemokine receptor 5 and CXC chemokine receptor 6 expression by lung CD8+ cells correlates with chronic obstructive pulmonary disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Characterization of the interstitial lung and peripheral blood T cell receptor repertoire in cigarette smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

TH17 cells in development: an updated view of their molecular identity and genetic programming

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Phenotypical and functional specialization of FOXP3+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

STAT4 activation in smokers and patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Th1/Th2 cells in inflammatory disease states: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Lung myeloid dendritic cells coordinately induce TH1 and TH17 responses in human emphysema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

CD8 positive T cells express IL-17 in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

High levels of lung resident CD4+CD28null cells in COPD: implications of autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Antielastin autoimmunity in tobacco smoking-induced emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Increase of Th17 cells in peripheral blood of patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Systemic CD4+ and CD8+ T-cell cytokine profiles correlate with GOLD stage in stable COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Myelin basic protein-specific TCR/HLA-DRB5*01:01 transgenic mice support the etiologic role of DRB5*01:01 in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Chronic cigarette smoke exposure generates pathogenic T cells capable of driving COPD-like disease in Rag2-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

T cell depletion protects against alveolar destruction due to chronic cigarette smoke exposure in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Autoantibodies in the grocery shop: does quantity matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Cigarette smoke-induced emphysema: A role for the B cell?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

CXCL13 production in B cells via Toll-like receptor/lymphotoxin receptor signaling is involved in lymphoid neogenesis in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Autoantibodies in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Antiendothelial Cell Antibodies in Patients With COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Novel autoantigens immunogenic in COPD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Identification and clinical association of anti-cytokeratin 18 autoantibody in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Increased incidence of autoimmune markers in patients with combined pulmonary fibrosis and emphysema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Anti-proline-glycine-proline or antielastin autoantibodies are not evident in chronic inflammatory lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Tolerogenic dendritic cells in autoimmune diseases: crucial players in induction and prevention of autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Evasion of COPD in smokers: at what price?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

The danger model: a renewed sense of self

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Cigarette smoke induced airway inflammation is independent of NF-κB signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Cigarette smoke increases TLR4 and TLR9 expression and induces cytokine production from CD8(+) T cells in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Expression of Toll-like receptor 2 is up-regulated in monocytes from patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Extracellular adenosine triphosphate and chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

An evolutionary history of P2X receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

P2X7 receptor and caspase 1 activation are central to airway inflammation observed after exposure to tobacco smoke

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Role of IL-1α and the Nlrp3/caspase-1/IL-1β axis in cigarette smoke-induced pulmonary inflammation and COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Acute cigarette smoke-induced connective tissue breakdown requires both neutrophils and macrophage metalloelastase in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Increased expression of nuclear factor-kappaB in bronchial biopsies from smokers and patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

The role of Toll-like receptors in non-infectious lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Airway epithelial cells, cytokines, and pollutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Dendritic cells in pathogenesis of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Anatomical location determines the distribution and function of dendritic cells and other APCs in the respiratory tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Pulmonary dendritic cells: thinking globally, acting locally

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Lymphocyte homing and homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Chronic obstructive pulmonary disease phenotypes: the future of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Treating human autoimmunity: current practice and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/ B7 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

The evolving clinical profile of abatacept (CTLA4-Ig): a novel co-stimulatory modulator for the treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Interleukin-10-secreting type 1 regulatory T cells in rodents and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

CD4+ T-regulatory cells: toward therapy for human diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Expansion of human regulatory T-cells from patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Immunological mechanisms of allergen-specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Facing a "slow-motion disaster"--the UN meeting on noncommunicable diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Dynamics of Dendritic Cell Phenotype and Interactions with CD4+ T Cells in Airway Inflammation and Tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Role of increased CD8/CD28(null) T cells and alternative co-stimulatory molecules in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

What Is Chronic Obstructive Pulmonary Disease Anyway?. Continua, Categories, Cut Points, and Moving beyond Spirometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Antinuclear autoantibodies are more prevalent in COPD in association with low body mass index but not with smoking history

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

The search for autoantibodies against elastin, collagen and decorin in COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Blunted T-lymphocyte response in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

HLA Distribution in COPD Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

Anti-Tissue Antibodies Are Related to Lung Function in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.828875

10.1586/1744666X.2013.828875

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference

PubMed ID

24070046